NYSE$HIMS
Hims & Hers Health Inc · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Reported strong Q1 2023 results with significant revenue growth and improved profitability.
Hims & Hers Health, Inc. reported an 88% year-over-year increase in revenue to $190.8 million for Q1 2023. The company achieved adjusted EBITDA profitability of $6.1 million and grew its subscriber base to over 1.2 million. They also raised the full year 2023 revenue guidance to a range of $810 million to $830 million and Adjusted EBITDA guidance to a range of $25 million to $30 million.
- Revenue increased by 88% year-over-year, reaching $190.8 million in Q1 2023.
- The company reported a net loss of $10.1 million, with adjusted EBITDA profitability of $6.1 million in Q1 2023.
- Subscribers grew to over 1.2 million, representing an 87% increase year-over-year in Q1 2023.
- Full year 2023 revenue guidance was raised to $810 million - $830 million and Adjusted EBITDA guidance to $25 million - $30 million.
Headline financials
Revenue & EPS history
Hims & Hers · Revenue · Quarterly
$191M
Revenue by segment
Hims & Hers · $191M total across 2 segments · Q1 2023
- Online Revenue$184M+95.7%96.5%
- Wholesale Revenue$6.6M-8.6%3.5%
Forward guidance
Hims & Hers provides revenue guidance of $200 million to $205 million and Adjusted EBITDA of $4 million to $7 million for the second quarter 2023. For the full year 2023, the Company expects revenue of $810 million to $830 million and Adjusted EBITDA of $25 million to $30 million.
Tailwinds
- Expects Q2 2023 revenue of $200 million to $205 million.
- Expects Q2 2023 Adjusted EBITDA of $4 million to $7 million.
- Projects full year 2023 revenue of $810 million to $830 million.
- Anticipates full year 2023 Adjusted EBITDA of $25 million to $30 million.
- Reflects an Adjusted EBITDA margin of 2% to 3% for Q2 2023.
Headwinds
- Guidance constitutes forward-looking statements and actual results may differ materially.
- Has not reconciled forward-looking Adjusted EBITDA to its most directly comparable U.S. GAAP measure, net loss.
- Cannot predict with reasonable certainty the ultimate outcome of certain components of such reconciliations.
- Unable to assess the probable significance of the unavailable information, which could materially impact the amount of future net loss.
- Market-related assumptions are not within their control.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2023
+2.5%
Avg return
Earnings day
+3.8%
Avg return
5 days after
+12.2%
Avg return
30 days after
50%
13 / 26 earnings
Positive
+41.1%
Q4 2023
Best reaction
-22.3%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.0% | -11.4% | — | |
| Q4 2025 | -2.8% | -6.4% | +34.5% | |
| Q3 2025 | -3.6% | -7.6% | -9.8% | |
| Q1 2025 | +18.5% | +24.1% | +26.0% | |
| Q4 2024 | -22.3% | -12.1% | -37.8% | |
| Q3 2024 | +1.4% | +15.0% | +66.6% | |
| Q2 2024 | -4.0% | -9.2% | -16.9% | |
| Q1 2024 | +9.7% | +9.1% | +93.2% | |
| Q4 2023 | +41.1% | +37.8% | +65.3% | |
| Q3 2023 | +7.6% | +5.1% | +37.3% | |
| Q2 2023 | -8.7% | -11.7% | -15.2% | |
| Q1 2023 | -11.5% | -10.2% | -23.9% | |
| Q4 2022 | +15.4% | +6.0% | +2.7% | |
| Q3 2022 | +30.1% | +37.2% | +64.7% | |
| Q2 2022 | -3.4% | +9.2% | -0.6% | |
| Q1 2022 | -13.0% | -13.5% | +5.3% | |
| Q4 2021 | +8.0% | +20.5% | +19.8% | |
| Q3 2021 | -7.0% | -1.3% | -26.3% | |
| Q2 2021 | +7.0% | -4.7% | +11.1% | |
| Q1 2021 | +13.7% | +44.9% | +33.1% | |
| Q2 2020 | -8.4% | -7.2% | -21.9% | |
| Q4 2020 | -7.5% | -15.4% | -21.3% | |
| Q3 2020 | +0.1% | +0.0% | +17.5% | |
| Q1 2020 | -0.7% | -0.5% | +0.1% | |
| Q4 2019 | +1.4% | +2.1% | +2.2% | |
| Q3 2019 | +0.0% | +0.3% | -0.6% | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro